Fruquintinib approved to enter the Japanese market
王俊杰2017
发表于 2024-9-24 20:41:54
174
0
0
Huahuang Pharmaceutical (China) Co., Ltd. (referred to as "Huahuang Pharmaceutical" or "HUTCHMED") announced that its partner Takeda has been approved by the Japanese Ministry of Health, Labour and Welfare to produce and sell FRUZAQLA (Fuquintinib) for the treatment of metastatic colorectal cancer patients. This means that Fruquintinib has become the first Chinese original new drug approved in the three major global mainstream markets of Europe, America, and Japan in Shanghai.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Japan sends a heavy signal! Potential interest rate hike risk: Japanese stock market hits hard
- The latest revelation confirms that the Bank of Japan is not in a hurry to raise interest rates in October, as the yen exchange rate falls to a critical level
- look out! The biggest 'thunder' in the global market is still hidden in Japan
- Black swan raid?! A historic moment for Japan!
- How does the market conduct the 'Trump deal' in depth?
- Sony's net profit increased by 37% from April to September, exceeding market expectations
- JD.com spends 10 billion yuan annually to attack the sinking market
- Throwing out billions of subsidies to seize the white card market, Jingxi self operated company has handed over a year's performance report
- Shigeru Ishiba is re elected as the Prime Minister of Japan
- Eli Lilly's new Alzheimer's disease drug Donanemab has been approved for pricing in Japan
-
"영비릉: 2024회계연도 영업수입 동기대비 8% 감소"영비릉은 2024회계연도 재무제보를 발표했다.2024 회계연도 매출은 149억5500만 유로로 전년 동기 대비 8% 감소했습니다.이익은 31억 500만 유로입니다.이익률은 ...- 勇敢的树袋熊1
- 3 일전
- Up
- Down
- Reply
- Favorite
-
계면신문기자 장우발 4분기의 영업수입이 하락한후 텐센트음악은 다시 성장으로 돌아왔다. 11월 12일, 텐센트음악은 최신 재보를 발표했다.2024년 9월 30일까지 이 회사의 3분기 총수입은 70억 2천만 위안으로 전년 ...
- 勇敢的树袋熊1
- 그저께 15:27
- Up
- Down
- Reply
- Favorite
-
본사소식 (기자 원전새): 11월 14일, 다다그룹 (나스닥코드: DADA) 은 2024년 3분기 실적보고를 발표했다. 수치가 보여준데 따르면 고품질발전전략에 지속적으로 전념하고 사용자체험을 끊임없이 최적화하며 공급을 ...- 家养宠物繁殖
- 어제 15:21
- Up
- Down
- Reply
- Favorite
-
11월 12일 소식에 따르면 소식통에 따르면 아마존은 무료스트리밍서비스 Freevee를 페쇄하고 일부 종업원과 프로를 구독서비스 Prime Video로 이전할 계획이다. 올해 초 아마존이 내놓은 몇 편의 대형 드라마의 효 ...- 度素告
- 그저께 13:58
- Up
- Down
- Reply
- Favorite
